Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Entrada Therapeutics, Inc. (TRDA)

NASDAQ

$6.73

$+0.00

(+0.07%)

Pre-Market

Entrada Therapeutics, Inc. (TRDA) Live Price Chart

Last updated: ⁦2026-09-16 12:10:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Entrada Therapeutics, Inc. (TRDA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.73, with a market capitalisation of $274.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.02 to $16.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$274.50M
Open	$6.72
Day's High	$36.85
Day's Low	$4.93
Previous Close	$6.88
Volume	--
Average Volume	366.08K
P/E Ratio	--
52-Week High	$16.45
52-Week Low	$5.02
Dividend Yield	--
Earnings Date	--

Entrada Therapeutics, Inc. (TRDA) Pre-Market Stock Price

Entrada Therapeutics, Inc. (TRDA) is trading at $6.73 in pre-market trading as of 2026-09-16 11:27:00, down 2.25% ($0.16) from the previous close of $6.88

Pre-market trading shows how investors are pricing TRDA before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Entrada Therapeutics, Inc. (TRDA) 7-Day Stock Price Change

Over the past seven days, Entrada Therapeutics, Inc. (TRDA) moved from $7.13 to $6.73, representing a decline of 5.68% ($0.41).

The stock traded between $6.29 and $7.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 365.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

TRDA 52-Week Price Position

Position in Range: 14.9%

52W Low$5.02

52W High$16.45

TRDA is currently trading at $6.73, placing it 14.9% of the way from its 52-week low of $5.02 to its 52-week high of $16.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Entrada Therapeutics, Inc. (TRDA)?

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Entrada Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	152
Exchange	NASDAQ
Company Website	https://www.entradatx.com

How to Buy Entrada Therapeutics, Inc. (TRDA) Stock on MEXC

Eligible investors can buy real shares of Entrada Therapeutics, Inc. (TRDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TRDA and Place Your Order

Open the RealStocks trading page and search for TRDA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Entrada Therapeutics, Inc. (TRDA) stock price today?

Entrada Therapeutics, Inc. (TRDA) is currently trading at $ 6.73, down 2.25% ($0.16) from the previous close of $ 6.88. Intraday prices update in real time during regular trading hours.

2.Is TRDA stock going up or down today?

As of 2026-09-16 11:27:00, TRDA is trading at $ 6.73, down 2.25% ($0.16) from its previous close of $ 6.88. The stock has traded between $ 4.93 and $ 36.85 during today’s regular session. Past price movements do not guarantee future results.

3.What is TRDA pre-market price?

As of 2026-09-16 11:27:00, TRDA is trading at $ 6.73 in pre-market trading, down 2.25% ($0.16) from the previous close of $ 6.88. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TRDA after-hours price?

As of 2026-09-16 11:27:00, TRDA is trading at $ 6.72 in after-hours trading, down 2.31% ($0.16) from the regular-session close of $ 6.88. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TRDA stock trading now?

TRDA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TRDA sit relative to its 52-week high and low?

Over the past 52 weeks, TRDA has traded between a low of $ 5.02 and a high of $ 16.45. At $ 6.73, the stock is positioned 14.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Entrada Therapeutics, Inc. in?

Entrada Therapeutics, Inc. (TRDA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Entrada Therapeutics, Inc.'s market capitalisation and where is it listed?

Entrada Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 274.50M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TRDA valued in terms of P/E ratio and EPS?

TRDA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.26. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Entrada Therapeutics, Inc. pay a dividend?

Entrada Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.